Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zithromax-SR 2g, Special Investigation For Skin And Soft Tissue Infection, Sexually-Transmitted Infection, And Infection Of The Oral (Regulatory Post Marketing Commitment Plan)

NCT00998309 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00998309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00998309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zithromax-SR 2g, Special Investigation For Skin And Soft Tissue Infection, Sexually-Transmitted Infection, And Infection Of The Oral (Regulatory Post Marketing Commitment Plan)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
January 31, 2011
Enrollment
502 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial infections